Elastographic and Ultrasonographic Evaluation of Patients With Breast Cancer Related Lymphedema
1 other identifier
observational
72
1 country
2
Brief Summary
The aim of this study is to evaluate the feasibility of shear-wave elastography for the diagnosis and staging of breast cancer related lymphedema by assessing the skin and subcutaneous tissues of the arm and forearm, which could serve as a reference standard and be more easily applicable in daily life; and to investigate the relationship between the patients' symptoms and elastographic measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 3, 2023
CompletedFirst Posted
Study publicly available on registry
August 24, 2023
CompletedAugust 24, 2023
August 1, 2023
2 months
February 3, 2023
August 20, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
B Mode Ultrasonography Measurements
Arm and forearm skin and subcutaneous tissue thicknesses in milimetres evaluated by B mode USG
Day 0
Shear Wave Elastography Measurements
Arm and forearm skin and subcutaneous tissue stiffness in kilopascal evaluated by Shear wave elastography
Day 0
B Mode Ultrasonography Measurements
Arm and forearm skin and subcutaneous tissue SEG and SEFS grades evaluated in echogenicity grade system by B mode USG
Day 0
Secondary Outcomes (4)
Association of USG and SWE Measurements With Symptoms
Day 0
Association of USG and SWE Measurements With Functionality
Day 0
Association of USG and SWE Measurements With Participation İn Daily Life
Day 0
Association of USG and SWE Measurements With Volume Measurements
Day 0
Study Arms (2)
Patient Group
Both Extremities of Patients With Breast Cancer Related Lymphedema
Control Group
Both Extremities of Healthy People With No History of Breast Cancer
Interventions
We evaluated the both upper extremities of the patient and control group with elastography and B mode ultrasonography. Shear wave elastography evaluates tissue deformation caused by acoustic radiation force. A highly focused ultrasound radiation is produced; The propagation speed of the shear wave depends on the stiffness of the tissue. It is a simple, inexpensive, bedside, widely available, non-invasive technique. B mode USG can be used to assess skin and subcutaneous tissue thickness and echogenicity. Skin and subcutaneous thickness were measured with b mode ultrasound. Skin and subcutaneous tissue stiffness was measured by shear wave ultrasonography
Quick-DASH is an assessment questionnaire that measures activity and participation limitations in all upper extremity disorders. In the questionnaire, the difficulties of the patients during their daily living activities are questioned with 11 questions. Each answer is scored from 1 to 5 on a Likert scale, from best to worst.
The Lymphedema Life Impact Scale is a questionnaire developed to evaluate the physical, functional and psychosocial effects of lymphedema. It consists of 18 questions; It includes 8 physical, 4 psychosocial and 6 functional subgroups. Each question is scored from 1 to 5, with higher scores indicating increased seriousness.
Arm pain and feeling of tension, heaviness and stiffness in the arm were evaluated separately by numerical scale. This scale is a 10 cm ruler that writes no pain, no tension, no heaviness, no stiffness on one side, and unbearable pain, tension and heaviness on the other side. Patients were asked to rate their associated symptoms on this scale between 0 and 10.
For the diagnosis of lymphedema, a detailed physical examination and extremity circumference were measured. This measurement was taken from both wrists to arm height with 4 cm intervals. Those with a circumference difference greater than 2 cm and/or no 10% volume difference were considered preclinical (latent) and those with clinical lymphedema.
Eligibility Criteria
In our study, individuals with breast cancer-related lymphedema diagnosis followed by Marmara University Pendik Training and Research Hospital Physical Medicine and Rehabilitation Department were included in the patient group, while upper extremity data of healthy volunteers without a known lymphedema history were controlled by one-to-one matching, considering the dominant and lymphedema sides of the patient group. included in the group.
You may qualify if:
- For the patient group
- between the ages of 18-75
- diagnosed with breast cancer-associated lymphedema by lymphoscintigraphy
- being stage 0-1-2 lymphedema according to ISL staging For the control group
- between the ages of 18-75
- no history of breast cancer
You may not qualify if:
- History of surgery in the assessment area
- History of trauma at the assessment site
- Active infection in the assessment area
- Presence of congenital or acquired malformations at the assessment site
- Primary lymphedema
- those with any medical condition that may cause edema, such as advanced heart or kidney failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Canan Şanal-Toprak
Istanbul, 34899, Turkey (Türkiye)
Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation
Istanbul, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
CANAN ŞANAL TOPRAK
Marmara University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2023
First Posted
August 24, 2023
Study Start
February 1, 2022
Primary Completion
April 1, 2022
Study Completion
November 1, 2022
Last Updated
August 24, 2023
Record last verified: 2023-08